{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:43:07Z","timestamp":1793479387859,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00140","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T01:21:57Z","timestamp":1526347317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?"],"prefix":"10.3389","volume":"5","author":[{"given":"Serena","family":"Bugatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garifallia","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terenzj","family":"Luvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Immacolata","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-156-5-201203060-00004","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial","volume":"156","author":"Bakker","year":"2012","journal-title":"Ann Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/annrheumdis-2013-204788","article-title":"Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial","volume":"73","author":"de Jong","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/annrheumdis-2016-209212","article-title":"Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial","volume":"76","author":"Verschueren","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/annrheumdis-2012-201456","article-title":"Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study","volume":"72","author":"Gremese","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/ar3838","volume":"14","author":"Montecucco","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1136\/annrheumdis-2017-211268","article-title":"Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort","volume":"76","author":"Gaujoux-Viala","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/acr.20021","article-title":"Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review","volume":"62","author":"van Tuyl","year":"2010","journal-title":"Arthritis Care Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","article-title":"(2015) American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/annrheumdis-2016-209201","article-title":"Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions","volume":"75","author":"Schett","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/annrheumdis-2017-212423","article-title":"Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis","volume":"77","author":"Henaux","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National cooperative Crohn's disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/ajg.2016.177","article-title":"Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn's disease","volume":"111","author":"Deepak","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11894-015-0477-6","article-title":"Understanding Endoscopic Disease Activity in IBD: How to incorporate it into practice","volume":"18","author":"Christensen","year":"2016","journal-title":"Curr Gastroenterol Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.crohns.2012.10.018","article-title":"Achievement of deep remission during scheduled maintenance therapy with TNF\u03b1-blocking agents in IBD","volume":"7","author":"Molander","year":"2013","journal-title":"J Crohns Colitis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3748\/wjg.14.348","article-title":"Epithelial restitution and wound healing in inflammatory bowel disease","volume":"14","author":"Sturm","year":"2008","journal-title":"World J Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/MIB.0000000000000155","article-title":"Assessment of histologic disease activity in Crohn's disease: a systematic review","volume":"20","author":"Mojtahed","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/art.21235","article-title":"Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states","volume":"52","author":"Aletaha","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/art.30634","article-title":"Joint damage in rheumatoid arthritis progresses in remission according to the disease activity score in 28 joints and is driven by residual swollen joints","volume":"63","author":"Aletaha","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e003554","DOI":"10.1136\/bmjopen-2013-003554","article-title":"Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria","volume":"3","author":"Svensson","year":"2013","journal-title":"BMJ Open"},{"key":"B24","first-page":"75","article-title":"Scores for all seasons: SDAI and CDAI","volume":"32","author":"Smolen","year":"2014","journal-title":"Clin Exp Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"Felson","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B26","first-page":"2016","article-title":"Minimal disease activity for rheumatoid arthritis: a preliminary definition","volume":"32","author":"Wells","year":"2005","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/03009742.2016.1266029","article-title":"Three out of four disease-modifying anti-rheumatic drug-na\u00efve rheumatoid arthritis patients meet 28-joint disease activity score remission at 12 months: results from the FIN-ERA cohort","volume":"46","author":"Rannio","year":"2017","journal-title":"Scand J Rheumatol."},{"key":"B28","first-page":"401","article-title":"In early inflammatory polyarthritis more intensive management according to the 2010 ACR\/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols","volume":"35","author":"Balduzzi","year":"2017","journal-title":"Clin Exp Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jbspin.2014.02.007","article-title":"Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis \u201cESPOIR\u201d cohort","volume":"81","author":"Hmamouchi","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.39945","article-title":"Comparative Assessment of the Different American College of Rheumatology\/European league against rheumatism remission definitions for rheumatoid arthritis for their use as clinical trial end points","volume":"69","author":"Mack","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1136\/annrheumdis-2016-209272","article-title":"Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial","volume":"75","author":"Kuijper","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar3027","article-title":"Time to achieve remission determines time to be in remission","volume":"12","author":"Schipper","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3899\/jrheum.140137","article-title":"Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis\u2013results from the Canadian Early Arthritis Cohort (CATCH)","volume":"41","author":"Kuriya","year":"2014","journal-title":"J Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/rheumatology\/kew210","article-title":"Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk arthritis register","volume":"55","author":"Cook","year":"2016","journal-title":"Rheumatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/acr.21762","article-title":"Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients","volume":"64","author":"Jawaheer","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/ard.2010.141234","article-title":"The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/annrheumdis-2017-211375","article-title":"Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: improved study","volume":"77","author":"Akdemir","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/art.24661","article-title":"Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts","volume":"60","author":"van der Woude","year":"2009"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X17720366","article-title":"Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations","volume":"9","author":"Ajeganova","year":"2017","journal-title":"Ther Adv Musculoskel Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/rheumatology\/kep442","article-title":"Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard","volume":"49","author":"Balsa","year":"2010","journal-title":"Rheumatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/annrheumdis-2012-201817","article-title":"In patients with early rheumatoid arthritis, the new ACR\/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis","volume":"72","author":"Sakellariou","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jbspin.2014.04.014","article-title":"Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and\/or the new ACR\/EULAR RA remission definitions: results of an observational cohort study","volume":"81","author":"Zufferey","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar4431","article-title":"Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers","volume":"16","author":"Ram\u00edrez","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13075-016-0970-9","article-title":"Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission","volume":"18","author":"Ram\u00edrez","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1136\/annrheumdis-2014-207212","article-title":"Persistence of subclinical sonographic joint activity in rheumatoid arthritis in sustained clinical remission","volume":"74","author":"G\u00e4rtner","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3899\/jrheum.110421","article-title":"Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state","volume":"38","author":"Gandjbakhch","year":"2011","journal-title":"J Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-015-0770-7","article-title":"Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study","volume":"17","author":"Gent","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/ard.2010.134445","article-title":"Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments","volume":"70","author":"Saleem","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/rheumatology\/kep171","article-title":"Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse","volume":"48","author":"Scir\u00e8","year":"2009","journal-title":"Rheumatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/ard.2010.129924","article-title":"Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis","volume":"70","author":"Peluso","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/rheumatology\/kew258","article-title":"Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology","volume":"55","author":"Bellis","year":"2016","journal-title":"Rheumatology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.11481","article-title":"Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission","volume":"50","author":"Molenaar","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/art.22190","article-title":"Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression","volume":"54","author":"Brown","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009742.2015.1070902","article-title":"MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis","volume":"45","author":"Forslind","year":"2016","journal-title":"Scand J Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"i4205","DOI":"10.1136\/bmj.i4205","article-title":"Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial","volume":"354","author":"Haavardsholm","year":"2016","journal-title":"BMJ"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/annrheumdis-2015-208941","article-title":"Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial","volume":"75","author":"Dale","year":"2016"},{"key":"B58","first-page":"607","article-title":"Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression","volume":"35","author":"Baker","year":"2017","journal-title":"Clin Exp Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/art.24646","article-title":"Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project","volume":"61","author":"Backhaus","year":"2009"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/rheumatology\/kes018","article-title":"A systematic literature review of US definitions, scoring systems and validity according to the OMERACT filter for tendon lesion in RA and other inflammatory joint diseases","volume":"51","author":"Alcalde","year":"2012","journal-title":"Rheumatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2017.115","article-title":"Synovial tissue research: a state-of-the-art review","volume":"13","author":"Orr","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrrheum.2016.193","article-title":"Immune resolution mechanisms in inflammatory arthritis","volume":"13","author":"Perretti","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1084\/jem.190.3.385","article-title":"Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis","volume":"190","author":"Rabinovich","year":"1999","journal-title":"J Exp Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1002\/art.23076","article-title":"Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts","volume":"56","author":"Seki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B66","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/er.2011-1016","article-title":"Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research","volume":"33","author":"B\u00f6hm","year":"2012","journal-title":"Endocr Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar2717","article-title":"Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids","volume":"11","author":"Gheorghe","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"420251","DOI":"10.1155\/2015\/420251","article-title":"The draining lymph node in rheumatoid arthritis: current concepts and research perspectives","volume":"2015","author":"Benaglio","year":"2015","journal-title":"Biomed Res Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrrheum.2017.205","article-title":"Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis","volume":"14","author":"Bouta","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1136\/annrheumdis-2016-210424","article-title":"Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?","volume":"76","author":"Alivernini","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/annrheumdis-2013-204229","article-title":"High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission","volume":"74","author":"Araujo","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.38273","article-title":"Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis","volume":"66","author":"de Hair","year":"2014","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00140\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T21:40:21Z","timestamp":1571348421000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2018.00140\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":74,"alternative-id":["10.3389\/fmed.2018.00140"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00140","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"article-number":"140"}}